Ketamine for Chronic Pain

Living with chronic pain means living with an invisible adversary that reshapes every aspect of daily life. When the alarm goes off in the morning, you already know what the day holds: stiffness, aching, burning, or stabbing sensations that no amount of ibuprofen, physical therapy, or willpower can fully quiet. For the estimated 50 million Americans living with chronic pain, the search for effective treatment can feel endless, especially when conventional medications offer diminishing returns.

Ketamine has been used for pain management since its introduction as an anesthetic in the 1960s. What makes it increasingly relevant today is our growing understanding of how chronic pain actually works at the neurological level, and why a drug that targets the NMDA receptor can address pain in ways that opioids and other analgesics cannot.

Understanding Chronic Pain

Chronic pain is defined as pain that persists beyond the normal tissue healing time, typically longer than 3 months. Unlike acute pain, which serves as a warning signal of tissue damage, chronic pain often continues after the original injury has healed, or arises without any identifiable injury at all.

The Central Sensitization Model

The modern understanding of chronic pain centers on a concept called central sensitization, a condition in which the central nervous system amplifies pain signals beyond what is warranted by actual tissue damage.⁴

In central sensitization:

• Spinal cord neurons become hyperexcitable, responding to normal sensory input as though it were painful
• Wind-up occurs when repeated stimulation causes progressively larger pain responses
• Allodynia develops, where normally non-painful sensations (a light touch, clothing on skin) are experienced as painful
• Hyperalgesia occurs, where mildly painful stimuli are perceived as intensely painful
• Expanded receptive fields mean that pain is felt in areas beyond the original injury site

The NMDA receptor plays a central role in the development and maintenance of central sensitization. When NMDA receptors are chronically activated, they facilitate the molecular and cellular changes that underlie pain amplification.⁶

Chronic Pain Conditions Treated with Ketamine

Ketamine has been studied and used clinically for several chronic pain conditions:

Complex Regional Pain Syndrome (CRPS)

CRPS is a severe chronic pain condition, typically affecting a limb after an injury, characterized by burning pain, swelling, skin color and temperature changes, and motor dysfunction. CRPS is believed to involve extreme central sensitization, making it a primary target for NMDA antagonist therapy. CRPS has the most evidence supporting ketamine treatment among all pain conditions.¹

Neuropathic Pain

Neuropathic pain results from damage or dysfunction of the nervous system itself. Conditions include diabetic neuropathy, post-herpetic neuralgia (pain after shingles), trigeminal neuralgia, and chemotherapy-induced peripheral neuropathy. Neuropathic pain is notoriously difficult to treat with opioids and often responds better to medications that target neural signaling, including ketamine.²

Fibromyalgia

Fibromyalgia is characterized by widespread musculoskeletal pain, fatigue, and cognitive difficulties. It is now understood as a central sensitization syndrome, making NMDA receptor blockade a rational treatment approach.⁷

Other Pain Conditions

Additional chronic pain conditions where ketamine has shown benefit include:

• Chronic migraines and cluster headaches
• Phantom limb pain following amputation
• Central pain syndrome (pain from spinal cord injury or stroke)
• Cancer-related pain, particularly neuropathic components
• Chronic post-surgical pain

How Ketamine Treats Chronic Pain

NMDA Receptor Blockade and Central Sensitization Reversal

Ketamine's primary mechanism for pain relief is blocking the NMDA receptor, which is a key mediator of central sensitization. By inhibiting this receptor:⁶

1. Wind-up is interrupted: The progressive amplification of pain signals is halted
2. Excitatory neurotransmission decreases: Excessive glutamate signaling in pain pathways is reduced
3. Spinal cord hyperexcitability diminishes: Dorsal horn neurons return toward normal sensitivity levels
4. Pain memory circuits are disrupted: The neural "memory" of chronic pain may be partially erased

Anti-inflammatory Effects

Chronic pain is frequently accompanied by neuroinflammation. Ketamine has demonstrated anti-inflammatory properties, including reduction of pro-inflammatory cytokines and modulation of microglial activation. These effects may contribute to pain relief, particularly in conditions where inflammation drives pain.¹⁰

Opioid-Sparing Properties

Ketamine interacts with the pain system in a way that can reduce opioid requirements. This is clinically important for several reasons:

• Patients on long-term opioids may develop opioid-induced hyperalgesia, where the opioids themselves increase pain sensitivity. Ketamine can counteract this effect⁸
• Reducing opioid doses decreases the risk of opioid side effects and dependence
• Ketamine does not cause respiratory depression, a leading cause of opioid overdose deaths
• Some pain management programs use ketamine infusions as part of opioid tapering protocols

Descending Pain Pathway Modulation

Beyond its direct effects on NMDA receptors, ketamine also modulates descending pain control pathways, the brain circuits that normally inhibit pain transmission at the spinal cord level. In chronic pain states, these descending inhibitory pathways often become dysfunctional. Ketamine may help restore their function.¹⁰

Research Evidence

The Sigtermans 2009 CRPS Study

The most significant controlled study of ketamine for chronic pain was the Sigtermans et al. randomized, double-blind, placebo-controlled trial of IV ketamine in CRPS patients.¹

Study design:

• 60 patients with CRPS Type 1 randomized to ketamine or normal saline
• Ketamine administered as a continuous infusion over 4 consecutive days (dose titrated to effect, range not to exceed sedation)
• Pain measured at multiple time points up to 12 weeks post-treatment

Key findings:

• Significant pain reduction in the ketamine group compared to placebo during treatment
• Pain relief was sustained for up to 12 weeks after the 4-day protocol
• Functional improvement accompanied pain reduction
• Quality of life measures improved significantly
• Side effects were manageable and resolved after treatment completion

This study remains the strongest evidence for ketamine in chronic pain and has influenced clinical protocols used by pain management centers worldwide.

Systematic Reviews and Meta-Analyses

A 2018 systematic review and meta-analysis of IV ketamine for CRPS examined data across multiple studies:⁵

• Consistent evidence of significant pain reduction across studies
• Effect sizes were clinically meaningful (typically 50% or greater pain reduction)
• Duration of benefit ranged from weeks to months depending on protocol
• Higher total ketamine exposure was associated with longer-lasting effects
• The evidence supported ketamine as a treatment option for CRPS patients who have failed conventional therapies

Fibromyalgia Evidence

A randomized, double-blind, placebo-controlled trial by Graven-Nielsen et al. examined IV ketamine in fibromyalgia patients:⁷

• Ketamine significantly reduced clinical fibromyalgia pain and referred pain areas
• Pain reduction correlated with reduced central sensitization markers
• Effects were temporary (lasting days rather than weeks), suggesting that repeated or prolonged infusions may be needed
• The study supported the central sensitization hypothesis for fibromyalgia

Neuropathic Pain Evidence

Multiple studies have demonstrated ketamine's efficacy for neuropathic pain conditions:²

• Consistent reduction in pain scores across neuropathic pain subtypes
• Particular benefit for allodynia (pain from normally non-painful stimuli)
• Benefit as adjunctive therapy alongside other neuropathic pain medications
• Potential role in opioid dose reduction for patients on chronic opioid therapy

Treatment Protocols for Pain

Standard Multi-Day Infusion Protocol

The most common approach for chronic pain conditions:

• Duration: 4-8 hours per day for 3-5 consecutive days
• Dose: Titrated from 0.1-0.5 mg/kg/hr, adjusted based on pain response and side effects
• Setting: Outpatient infusion center with continuous monitoring
• Monitoring: Blood pressure, heart rate, oxygen saturation, pain scores, and mental status checks every 30-60 minutes
• Adjunct medications: Anti-nausea medication, clonidine for blood pressure management

Single-Day or Short Infusion Protocol

For less severe conditions or as maintenance:

• Duration: 2-4 hours
• Dose: 0.5-1.0 mg/kg total, titrated over the infusion period
• Frequency: Repeated every 2-8 weeks as needed
• Suitable for: Maintenance after initial multi-day series, fibromyalgia, chronic migraines

Intensive Protocols for Severe CRPS

Some specialized pain centers offer higher-dose, longer-duration protocols:

• Multi-day infusions in monitored settings (sometimes inpatient)
• Higher total ketamine doses with intensive medical supervision
• Reserved for severe, refractory CRPS that has not responded to standard protocols
• Requires experienced anesthesiology and pain medicine teams

Learn more about IV ketamine infusions

What to Expect During Treatment

Pain-Specific Considerations

Ketamine infusions for chronic pain differ from depression protocols in several important ways:

• Longer sessions: Expect 4-8 hours per session versus 40 minutes for depression
• Higher doses: Pain protocols use more ketamine, so dissociative effects may be more pronounced
• Multi-day commitment: A typical course requires 3-5 consecutive days of treatment
• Overnight stays: Some intensive protocols may require staying near the clinic or an overnight clinical observation
• Delayed response: While some patients notice pain relief during the infusion itself, maximum benefit often develops over the days following completion of the full course

Before Your Treatment Course

• Medication review: Discuss all current pain medications with your provider; some may need adjustment
• Opioid considerations: If you are on opioids, your provider will advise on dosing during the ketamine course
• Arrange transportation and support: You will not be able to drive during the treatment days; plan for a ride each day or stay near the clinic
• Set realistic expectations: Ketamine is not a cure for chronic pain. The goal is meaningful pain reduction and improved function, not necessarily complete pain elimination

During Infusions

• You will be in a comfortable treatment room with continuous monitoring
• Sessions are longer, so bring entertainment: audiobooks, music, podcasts
• You may eat light meals during longer infusions (discuss with your clinic)
• Staff will check your pain levels periodically during the infusion
• Dissociative effects are expected and managed; do not be alarmed by altered perception

After Your Treatment Course

• Pain levels may fluctuate over the first 1-2 weeks as the full effect develops
• Keep a pain diary to track changes in intensity, location, and quality
• Continue physical therapy and rehabilitation as recommended
• Report any concerning side effects to your provider

Read our complete guide to what to expect during ketamine therapy

Candidate Screening and Contraindications

Ideal Candidates

Ketamine for chronic pain is most appropriate for:

• Patients with CRPS (especially Type 1) who have not responded to standard treatments
• Those with neuropathic pain conditions resistant to gabapentinoids and other first-line neuropathic pain medications
• Patients seeking to reduce opioid dependence while maintaining pain control
• Individuals with fibromyalgia who have not responded to approved fibromyalgia medications
• Cancer patients with neuropathic pain components
• Those with central sensitization features (allodynia, hyperalgesia, expanded pain areas)

Contraindications for Pain Patients

In addition to standard ketamine contraindications:

• Uncontrolled hypertension: Higher doses and longer durations increase cardiovascular monitoring requirements
• Active substance use disorders: Careful assessment needed, especially for patients with opioid use disorder
• Hepatic impairment: Ketamine is metabolized by the liver; prolonged courses require liver function monitoring
• Urological issues: Higher cumulative ketamine doses carry increased risk of bladder toxicity; baseline and follow-up urological assessments are recommended for patients receiving frequent treatments
• Cognitive impairment: Higher doses may cause more pronounced cognitive effects; consider carefully for patients with baseline cognitive difficulties

Cost and Insurance

Pricing for Chronic Pain Treatment

Pain-focused ketamine protocols are generally more expensive than depression protocols due to higher doses and longer treatment times:

• Multi-day infusion series: $3,000-$10,000 for a 3-5 day outpatient protocol
• Single-day maintenance infusions: $500-$2,000 per session (4-8 hours)
• Intensive inpatient protocols: $5,000-$25,000+ (for severe, refractory CRPS at specialized centers)
• Initial consultation with pain specialist: $200-$500

Insurance and Coverage Options

• Coverage is more possible for pain than for psychiatric conditions, particularly for CRPS
• Workers compensation may cover ketamine for work-related pain injuries
• Prior authorization with documentation of failed treatments may succeed with some insurers
• Letter of medical necessity from your pain specialist can support coverage appeals
• HSA/FSA accounts can be used for ketamine pain treatments
• Many pain clinics offer payment plans

See our complete guide to ketamine costs

Finding a Pain Specialist

For chronic pain treatment, look for providers with:

• Board certification in pain medicine or anesthesiology with pain management fellowship
• Specific experience with ketamine infusion protocols for pain (not just depression protocols)
• Ability to provide extended infusions (4-8 hours) with appropriate monitoring equipment
• Multi-day protocol capabilities for CRPS and other conditions requiring intensive treatment
• Collaborative relationships with physical therapists, occupational therapists, and other pain rehabilitation professionals
• Experience managing complex pain medications including safe opioid tapering when appropriate

Find a ketamine clinic near you

Chronic pain is a real medical condition that deserves effective treatment. If you are struggling with chronic pain and feel you have exhausted your options, ketamine therapy may offer meaningful relief. Always work with a qualified pain management specialist to determine the right approach for your individual situation.